NCR1 and Patent ductus arteriosus: To complement the cytokine analyses and assess the stromal immune cell presence, we systematically performed immunohistochemistry in the same PDA tissues using a variety of immune cell markers (CD3, CD4, CD8, FoxP3, CD20, CD163, NKp46) and quantified positively stained cells.